Drug Shortage Report for CERVARIX

Last updated on 2018-11-15 History
Report ID 45668
Drug Identification Number 02342227
Brand name CERVARIX
Common or Proper name Human Papillomavirus vaccine Types 16 and 18
Company Name GLAXOSMITHKLINE INC
Market Status MARKETED
Active Ingredient(s) RECOMBINANT HUMAN PAPILLOMAVIRUS TYPE 16 L1 PROTEIN RECOMBINANT HUMAN PAPILLOMAVIRUS TYPE 18 L1 PROTEIN
Strength(s) 20MCG 20MCG
Dosage form(s) SUSPENSION
Route of administration INTRAMUSCULAR
Packaging size 1's
ATC code J07BM
ATC description VIRAL VACCINES
Reason for shortage Other (Please describe in comments)
Anticipated start date
Actual start date 2018-04-09
Estimated end date 2018-11-15
Actual end date 2018-11-14
Shortage status Resolved
Updated date 2018-11-15
Company comments
Health Canada comments
Company contact information 1-800-387-7374

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v11 2018-11-15 English Compare
v10 2018-11-14 French Compare
v9 2018-11-14 English Compare
v8 2018-10-10 French Compare
v7 2018-10-10 English Compare
v6 2018-07-11 French Compare
v5 2018-07-11 English Compare
v4 2018-07-06 French Compare
v3 2018-07-06 English Compare
v2 2018-04-13 French Compare
v1 2018-04-13 English Compare